规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | The Werner syndrome helicase (WRN) is an ATP-dependent helicase with 3' to 5' DNA exonuclease activity that regulates the replicative potential of dividing cells, and WRN loss-of-function mutations promote cellular senescence and neoplastic transformation[2]. WRN helicase has several roles in genome maintenance, such as replication, base excision repair, recombination, DNA damage response and transcription. These processes are often found upregulated in human cancers, many of which display increased levels of WRN[3]. WRN depletion in HeLa cells attenuates global protein synthesis without affecting the level of key components of the mRNA export machinery. WRN depletion affects the nuclear export of mRNAs and demonstrated that WRN interacts with mRNA and the Nuclear RNA Export Factor 1 (NXF1)[4]. NSC617145 is a WRN helicase inhibitor. In FA-D2(-/-) cells, NSC 617145 acted synergistically with very low concentrations of mitomycin C to inhibit proliferation in a WRN-dependent manner and induce double-strand breaks (DSB) and chromosomal abnormalities. Under these conditions, ataxia-telangiectasia mutated activation and accumulation of DNA-dependent protein kinase, catalytic subunit pS2056 foci suggested an increased number of DSBs processed by nonhomologous end-joining (NHEJ). Rad51 foci were also elevated in FA-D2(-/-) cells exposed to NSC 617145 and mitomycin C, suggesting that WRN helicase inhibition interferes with later steps of homologous recombination at ICL-induced DSBs[5]. |
Concentration | Treated Time | Description | References | |
U2OS cells | 1.5 µM | 2 days | NSC 617145 inhibits cell proliferation, independent of p53 status | Cancer Res. 2013 Sep 1;73(17):5497-507 |
HeLa cells | 1.5 µM | 3 days | NSC 617145 inhibits cell proliferation in a WRN-dependent manner | Cancer Res. 2013 Sep 1;73(17):5497-507 |
MO59J cells | 0.5 µM | 3 days | WRN helicase inhibition in cells deficient in both FA and NHEJ pathways further compromises their ability to proliferate | Cell Cycle. 2013 Oct 15;12(20):3329-35 |
MO59K cells | 0.5 µM | 3 days | WRN helicase inhibition causes greater genomic instability when NHEJ is operational | Cell Cycle. 2013 Oct 15;12(20):3329-35 |
Human endocervical carcinoma cells | 0.5 µM | 3 days | Inhibition of WRN helicase activity, resulting in decreased cell proliferation and accumulation of DNA damage and chromosomal abnormalities | Cell Cycle. 2013 Oct 15;12(20):3329-35 |
ATL-derived cell lines (ED, TL, ATL-25, ATL-43T, ATL-55T, LMY1, KK1, SO4, KOB) | 0.02, 0.2, 2, 20 µM | 72 hours | Inhibition of cellular growth and induction of apoptosis | J Hematol Oncol. 2016 Nov 9;9(1):121 |
HTLV-1-transformed cell lines (MT-4, C8166, C91PL, 1186.94) | 0.02, 0.2, 2, 20 µM | 72 hours | Inhibition of cellular growth and induction of apoptosis | J Hematol Oncol. 2016 Nov 9;9(1):121 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.50mL 0.50mL 0.25mL |
12.50mL 2.50mL 1.25mL |
25.00mL 5.00mL 2.50mL |
CAS号 | 203115-63-3 |
分子式 | C13H10Cl4N2O4 |
分子量 | 400.04 |
SMILES Code | CC(CN1C(C(Cl)=C(Cl)C1=O)=O)(C)CN2C(C(Cl)=C(Cl)C2=O)=O |
MDL No. | MFCD28100812 |
别名 | |
运输 | 蓝冰 |
InChI Key | PCOXPBOKDABARQ-UHFFFAOYSA-N |
Pubchem ID | 357621 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
溶解方案 |
DMSO: 9 mg/mL(22.5 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|